Freedom Bio (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$120,000,000
Company Info
Founders
Dina Burkitbayeva
Market
Healthcare & Wellness
Coinvestors
Negev Capital,Manta Ray,Village Global
Company Description

Developer of a biotech platform designed to address the biggest shortcoming of first-generation psychedelics. Freedom Biosciences is a biotechnology platform developing next-generation psychedelic therapeutics.